Media headlines about Vision Sciences (NASDAQ:CGNT) have been trending positive on Thursday, according to Accern Sentiment. The research group scores the sentiment of media coverage by monitoring more than 20 million news and blog sources in real time. Accern ranks coverage of companies on a scale of negative one to one, with scores closest to one being the most favorable. Vision Sciences earned a news sentiment score of 0.28 on Accern’s scale. Accern also gave media stories about the medical device company an impact score of 44.7057331506653 out of 100, indicating that recent media coverage is somewhat unlikely to have an effect on the stock’s share price in the near term.
These are some of the media stories that may have impacted Accern Sentiment’s scoring:
- Vision Sciences Inc. (CGNT) Given $4.23 Average Target Price by Analysts (americanbankingnews.com)
- Vision Sciences (CGNT) Stock Rating Upgraded by Zacks Investment Research (americanbankingnews.com)
- Roth Capital Initiates Coverage on Vision Sciences (CGNT) (americanbankingnews.com)
- Is It Time To Buy Cogentix Medical Inc (NASDAQ:CGNT)? (finance.yahoo.com)
Several equities analysts have recently commented on the stock. Zacks Investment Research raised shares of Vision Sciences from a “hold” rating to a “buy” rating and set a $4.25 price target on the stock in a research report on Monday. Roth Capital cut shares of Vision Sciences from a “buy” rating to a “hold” rating and set a $4.00 price target on the stock. in a research report on Friday, March 23rd. Finally, Aegis cut shares of Vision Sciences from a “buy” rating to a “hold” rating and set a $4.75 price target on the stock. in a research report on Tuesday, March 13th. Two investment analysts have rated the stock with a hold rating and two have given a buy rating to the company. The stock currently has a consensus rating of “Buy” and a consensus price target of $4.50.
Vision Sciences Company Profile
Cogentix Medical, Inc, a medical device company, designs, develops, manufactures, and markets fiberoptic and video endoscopy products under the PrimeSight brand worldwide. The company offers endoscopes, such as cystoscopes, laryngoscopes, transnasal esophagoscopes, and bronchoscopes for medical use; and borescopes for industrial use, as well as digital processing units for medical use.
Receive News & Ratings for Vision Sciences Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Vision Sciences and related companies with MarketBeat.com's FREE daily email newsletter.